Status:

COMPLETED

Photographic Imaging of the Retina and Optic Nerve Head of Glaucoma Patients and Normal Controls

Lead Sponsor:

Selim Orguel

Conditions:

Glaucoma

Eligibility:

All Genders

45-80 years

Brief Summary

Retinal structures are difficult to visualize because the retina is optically transparent. In glaucoma, the microglia in the retina becomes activated in eyes with glaucomatous damage. The microglia fo...

Detailed Description

Glaucoma is an optic neuropathy characterized by a progressive loss of retinal ganglion cells and cupping of the optic nerve head associated with visual function defects. Increased intraocular pressur...

Eligibility Criteria

Inclusion

  • For NTG patients :
  • untreated intraocular pressure equal to or less than 21mmHg or
  • median intraocular pressure equal to or less than 20mmHg
  • For HTG patients:
  • mean untreated intraocular pressure more than 21mmHg
  • For both:
  • open drainage angles on gonioscopy
  • typical optic disc damage with glaucomatous cupping and thinning of neuroretinal rim
  • absence of any secondary cause for a glaucomatous optic neuropathy
  • visual field defects congruent to glaucomatous disc damage (disc/field correlation)
  • Healthy subjects:
  • no history of ocular diseases
  • no current topical medication
  • no drug or alcohol abuse
  • best corrected visual acuity above 20/25 in both eyes
  • no pathological findings upon a slit-lamp examination and fundoscopy
  • IOP \< 21 mmHg in both eyes

Exclusion

  • For NTG and HTG patients:
  • any other form of retinal or neuroophthalmological disease that could cause gliosis-like retinal alterations or result in visual field defects
  • history of chronic or recurrent severe inflammatory eye disease
  • history of ocular trauma or intraocular surgery
  • history of infection or inflammation within the past 3 months
  • history and clinical evidence for other retinal disease

Key Trial Info

Start Date :

January 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2017

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT00430274

Start Date

January 1 2006

End Date

April 1 2017

Last Update

August 25 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Eye Clinic

Basel, Switzerland, 4031